Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells

The aim of the present study was to analyze the influence of virus origin, mammalian or mosquito cell-derived, on antiviral susceptibility of DENV-2 to entry inhibitors and the association of this effect with any alteration in the mode of entry into the cell. To this end, ten serial passages of DENV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Acosta, E.G., Piccini, L.E., Talarico, L.B., Castilla, V., Damonte, E.B.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_01681702_v184_n_p39_Acosta
Aporte de:
id todo:paper_01681702_v184_n_p39_Acosta
record_format dspace
spelling todo:paper_01681702_v184_n_p39_Acosta2023-10-03T15:06:14Z Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells Acosta, E.G. Piccini, L.E. Talarico, L.B. Castilla, V. Damonte, E.B. Antiviral activity Carrageenan Clathrin-mediated endocytosis Dengue virus Entry inhibitor Sulfated polysaccharide carrageenan chlorpromazine heparin antivirus agent carrageenan heparin virus RNA antiviral activity antiviral susceptibility article controlled study Dengue virus 1 Dengue virus 2 endocytosis host cell in vitro study nonhuman priority journal Vero cell virus entry adaptation animal antiviral resistance cell line Chlorocebus aethiops Dengue virus DNA sequence drug effects genetics growth, development and aging molecular genetics mosquito nucleotide sequence viral plaque assay virus culture Adaptation, Biological Animals Antiviral Agents Carrageenan Cell Line Cercopithecus aethiops Culicidae Dengue Virus DNA Mutational Analysis Drug Resistance, Viral Endocytosis Heparin Molecular Sequence Data RNA, Viral Sequence Analysis, DNA Serial Passage Viral Plaque Assay Virus Internalization The aim of the present study was to analyze the influence of virus origin, mammalian or mosquito cell-derived, on antiviral susceptibility of DENV-2 to entry inhibitors and the association of this effect with any alteration in the mode of entry into the cell. To this end, ten serial passages of DENV-2 were performed in mosquito C6/36 cells or monkey Vero cells and the antiviral susceptibility of each virus passage to sulfated polysaccharides (SPs), like heparin and carrageenans, was evaluated by a virus plaque reduction assay. After serial passaging in Vero cells, DENV-2 became increasingly resistant to SP inhibition whereas the antiviral susceptibility was not altered in virus propagated in C6/36 cells. The change in antiviral susceptibility was associated to a differential mode of entry into the host cell. The route of endocytic entry for productive Vero cell infection was altered from a non-classical clathrin independent pathway for C6/36-grown virus to a clathrin-mediated endocytosis when the virus was serially propagated in Vero cells. Our results show the impact of the cellular system used for successive propagation of DENV on the initial interaction between the host cell and the virion in the next round of infection and the relevant consequences it might have during the in vitro evaluation of entry inhibitors. © 2014 Elsevier B.V. Fil:Acosta, E.G. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Talarico, L.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Castilla, V. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Damonte, E.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_01681702_v184_n_p39_Acosta
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antiviral activity
Carrageenan
Clathrin-mediated endocytosis
Dengue virus
Entry inhibitor
Sulfated polysaccharide
carrageenan
chlorpromazine
heparin
antivirus agent
carrageenan
heparin
virus RNA
antiviral activity
antiviral susceptibility
article
controlled study
Dengue virus 1
Dengue virus 2
endocytosis
host cell
in vitro study
nonhuman
priority journal
Vero cell
virus entry
adaptation
animal
antiviral resistance
cell line
Chlorocebus aethiops
Dengue virus
DNA sequence
drug effects
genetics
growth, development and aging
molecular genetics
mosquito
nucleotide sequence
viral plaque assay
virus culture
Adaptation, Biological
Animals
Antiviral Agents
Carrageenan
Cell Line
Cercopithecus aethiops
Culicidae
Dengue Virus
DNA Mutational Analysis
Drug Resistance, Viral
Endocytosis
Heparin
Molecular Sequence Data
RNA, Viral
Sequence Analysis, DNA
Serial Passage
Viral Plaque Assay
Virus Internalization
spellingShingle Antiviral activity
Carrageenan
Clathrin-mediated endocytosis
Dengue virus
Entry inhibitor
Sulfated polysaccharide
carrageenan
chlorpromazine
heparin
antivirus agent
carrageenan
heparin
virus RNA
antiviral activity
antiviral susceptibility
article
controlled study
Dengue virus 1
Dengue virus 2
endocytosis
host cell
in vitro study
nonhuman
priority journal
Vero cell
virus entry
adaptation
animal
antiviral resistance
cell line
Chlorocebus aethiops
Dengue virus
DNA sequence
drug effects
genetics
growth, development and aging
molecular genetics
mosquito
nucleotide sequence
viral plaque assay
virus culture
Adaptation, Biological
Animals
Antiviral Agents
Carrageenan
Cell Line
Cercopithecus aethiops
Culicidae
Dengue Virus
DNA Mutational Analysis
Drug Resistance, Viral
Endocytosis
Heparin
Molecular Sequence Data
RNA, Viral
Sequence Analysis, DNA
Serial Passage
Viral Plaque Assay
Virus Internalization
Acosta, E.G.
Piccini, L.E.
Talarico, L.B.
Castilla, V.
Damonte, E.B.
Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
topic_facet Antiviral activity
Carrageenan
Clathrin-mediated endocytosis
Dengue virus
Entry inhibitor
Sulfated polysaccharide
carrageenan
chlorpromazine
heparin
antivirus agent
carrageenan
heparin
virus RNA
antiviral activity
antiviral susceptibility
article
controlled study
Dengue virus 1
Dengue virus 2
endocytosis
host cell
in vitro study
nonhuman
priority journal
Vero cell
virus entry
adaptation
animal
antiviral resistance
cell line
Chlorocebus aethiops
Dengue virus
DNA sequence
drug effects
genetics
growth, development and aging
molecular genetics
mosquito
nucleotide sequence
viral plaque assay
virus culture
Adaptation, Biological
Animals
Antiviral Agents
Carrageenan
Cell Line
Cercopithecus aethiops
Culicidae
Dengue Virus
DNA Mutational Analysis
Drug Resistance, Viral
Endocytosis
Heparin
Molecular Sequence Data
RNA, Viral
Sequence Analysis, DNA
Serial Passage
Viral Plaque Assay
Virus Internalization
description The aim of the present study was to analyze the influence of virus origin, mammalian or mosquito cell-derived, on antiviral susceptibility of DENV-2 to entry inhibitors and the association of this effect with any alteration in the mode of entry into the cell. To this end, ten serial passages of DENV-2 were performed in mosquito C6/36 cells or monkey Vero cells and the antiviral susceptibility of each virus passage to sulfated polysaccharides (SPs), like heparin and carrageenans, was evaluated by a virus plaque reduction assay. After serial passaging in Vero cells, DENV-2 became increasingly resistant to SP inhibition whereas the antiviral susceptibility was not altered in virus propagated in C6/36 cells. The change in antiviral susceptibility was associated to a differential mode of entry into the host cell. The route of endocytic entry for productive Vero cell infection was altered from a non-classical clathrin independent pathway for C6/36-grown virus to a clathrin-mediated endocytosis when the virus was serially propagated in Vero cells. Our results show the impact of the cellular system used for successive propagation of DENV on the initial interaction between the host cell and the virion in the next round of infection and the relevant consequences it might have during the in vitro evaluation of entry inhibitors. © 2014 Elsevier B.V.
format JOUR
author Acosta, E.G.
Piccini, L.E.
Talarico, L.B.
Castilla, V.
Damonte, E.B.
author_facet Acosta, E.G.
Piccini, L.E.
Talarico, L.B.
Castilla, V.
Damonte, E.B.
author_sort Acosta, E.G.
title Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
title_short Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
title_full Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
title_fullStr Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
title_full_unstemmed Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells
title_sort changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in vero or c6/36 cells
url http://hdl.handle.net/20.500.12110/paper_01681702_v184_n_p39_Acosta
work_keys_str_mv AT acostaeg changesinantiviralsusceptibilitytoentryinhibitorsandendocyticuptakeofdengue2virusseriallypassagedinveroorc636cells
AT piccinile changesinantiviralsusceptibilitytoentryinhibitorsandendocyticuptakeofdengue2virusseriallypassagedinveroorc636cells
AT talaricolb changesinantiviralsusceptibilitytoentryinhibitorsandendocyticuptakeofdengue2virusseriallypassagedinveroorc636cells
AT castillav changesinantiviralsusceptibilitytoentryinhibitorsandendocyticuptakeofdengue2virusseriallypassagedinveroorc636cells
AT damonteeb changesinantiviralsusceptibilitytoentryinhibitorsandendocyticuptakeofdengue2virusseriallypassagedinveroorc636cells
_version_ 1807316204827705344